Suchergebnisse - "Moorkens, Evelien"

PubPharm (24)

1

A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars : An ISPOR Special Interest Group Report

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2023

von Moorkens, E. | Lacosta, T. | Dawoud, D. | +7

2

Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma : Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice

enthalten in: HemaSphere | 2022

von Delforge, M. | Vekemans, M. | Depaus, J. | +13

3

How to balance valuable innovation with affordable access to medicines in Belgium?

enthalten in: Frontiers in pharmacology | 2022

von Simoens, S. | Abdallah, K. | Barbier, L. | +16

4

Biosimilars in Belgium : a proposal for a more competitive market

enthalten in: Acta clinica Belgica | 2021

von Moorkens, E. | Vulto, A. | Huys, I.

5

A Look at the History of Biosimilar Adoption : Characteristics of Early and Late Adopters of Infliximab and Etanercept Biosimilars in Subregions of England, Scotland and Wales - A Mixed Methods Study

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2021

von Moorkens, E. | Vulto, A. | Kent, J. | +5

6

A Look at the History of Biosimilar Adoption: Characteristics of Early and Late Adopters of Infliximab and Etanercept Biosimilars in Subregions of England, Scotland and Wales - A Mixed Methods Study

enthalten in: BioDrugs | 2020

von Moorkens, E. | Vulto, A. | Kent, J. | +5

7

A Look at the History of Biosimilar Adoption: Characteristics of Early and Late Adopters of Infliximab and Etanercept Biosimilars in Subregions of England, Scotland and Wales - A Mixed Methods Study

enthalten in: BioDrugs | 2020

von Moorkens, E. | Vulto, A. | Kent, J. | +5

8

A Look at the History of Biosimilar Adoption: Characteristics of Early and Late Adopters of Infliximab and Etanercept Biosimilars in Subregions of England, Scotland and Wales - A Mixed Methods Study

enthalten in: BioDrugs | 2020

von Moorkens, E. | Vulto, A. | Kent, J. | +5

9

Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2020

von Moorkens, E. | Barcina Lacosta, T. | Vulto, A. | +6

10

Economic evaluation of biosimilars for reimbursement purposes - what, when, how?

enthalten in: Journal of market access & health policy | 2020

von Moorkens, E. | Broux, H. | Huys, I. | +2